Literature DB >> 23606190

Depression and smoking: a 5-year prospective study of patients with major depressive disorder.

Irina A K Holma1, K Mikael Holma, Tarja K Melartin, Mikko Ketokivi, Erkki T Isometsä.   

Abstract

BACKGROUND: Major depressive disorder (MDD) and smoking are major public health problems and epidemiologically strongly associated. However, the relationship between smoking and depression and whether this is influenced by common confounding factors remain unclear, in part due to limited longitudinal data on covariation.
METHODS: In the Vantaa Depression Study, psychiatric out- and inpatients with DSM-IV MDD and aged 20-59 years at were followed from baseline to 6 months, 18 months, and 5 years. We investigated course of depression, smoking, and comorbid alcohol-use disorders among the 214 patients (79.6% of 269) participating at least three time points; differences between smoking versus nonsmoking patients, and covariation of MDD, smoking, and alcohol-use disorders.
RESULTS: Overall, 31.3% of the patients smoked regularly, 41.1% intermittently, and 27.6% never. Smokers were younger, had more alcohol-use disorders and Cluster B and C personality disorder symptoms, a higher frequency of lifetime suicide attempts, higher neuroticism, smaller social networks, and lower perceived social support than never smokers. Smoking and depression had limited longitudinal covariation. Depression, smoking, and alcohol-use disorders all exhibited strong autoregressive tendencies.
CONCLUSIONS: Among adult psychiatric MDD patients, smoking is strongly associated with substance-use and personality disorders, which may confound research on the impact of smoking. Rather than depression or smoking covarying or predicting each other, depression, smoking, and alcohol-use disorders each have strong autoregressive tendencies. These findings are more consistent with common factors causing their association than either of the conditions strongly predisposing to the other.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23606190     DOI: 10.1002/da.22108

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  14 in total

1.  An Examination of the Sociodemographic and Health Determinants of Major Depressive Disorder Among Black Women.

Authors:  Ndidiamaka N Amutah-Onukagha; Lauren A Doamekpor; Michelle Gardner
Journal:  J Racial Ethn Health Disparities       Date:  2016-12-07

2.  Smoking- and menstrual-related symptomatology during short-term smoking abstinence by menstrual phase and depressive symptoms.

Authors:  Sharon S Allen; Alicia M Allen; Nicole Tosun; Scott Lunos; Mustafa al'Absi; Dorothy Hatsukami
Journal:  Addict Behav       Date:  2014-02-13       Impact factor: 3.913

3.  Trajectories of Cigarette Smoking Beginning in Adolescence Predict Insomnia in the Mid Thirties.

Authors:  Jung Yeon Lee; Judith S Brook; Stephen J Finch; David W Brook
Journal:  Subst Use Misuse       Date:  2016-03-23       Impact factor: 2.164

4.  Smoking and Smoking Increase in Caregivers of Alzheimer's Patients.

Authors:  Francisco I Salgado-García; Jeffrey K Zuber; Marshall J Graney; Linda O Nichols; Jennifer L Martindale-Adams; Frank Andrasik
Journal:  Gerontologist       Date:  2013-12-26

5.  Synergistic anticataleptic effect of imipramine and nicotine in a rotenone-induced rat model.

Authors:  Ilya D Ionov; Irina I Pushinskaya; Nicholas P Gorev; Larissa A Shpilevaya
Journal:  Psychopharmacology (Berl)       Date:  2019-05-08       Impact factor: 4.415

6.  Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study.

Authors:  Yasmina Molero; Paul Lichtenstein; Johan Zetterqvist; Clara Hellner Gumpert; Seena Fazel
Journal:  BMJ       Date:  2015-06-02

7.  Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.

Authors:  Petra Amchova; Jana Kucerova; Valentina Giugliano; Zuzana Babinska; Mary T Zanda; Maria Scherma; Ladislav Dusek; Paola Fadda; Vincenzo Micale; Alexandra Sulcova; Walter Fratta; Liana Fattore
Journal:  Front Pharmacol       Date:  2014-03-20       Impact factor: 5.810

8.  Hazardous drinking-related characteristics of depressive disorders in Korea: the CRESCEND study.

Authors:  Seon-Cheol Park; Sang Kyu Lee; Hong Seok Oh; Tae-Youn Jun; Min-Soo Lee; Jae-Min Kim; Jung-Bum Kim; Hyeon-Woo Yim; Yong Chon Park
Journal:  J Korean Med Sci       Date:  2014-12-23       Impact factor: 2.153

9.  Prevalence of smoking in patients with bipolar disorder, major depressive disorder and schizophrenia and their relationships with quality of life.

Authors:  Xiao-Hong Li; Feng-Rong An; Gabor S Ungvari; Chee H Ng; Helen F K Chiu; Ping-Ping Wu; Xin Jin; Yu-Tao Xiang
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

10.  Correlation of Axial Spondyloarthritis with Anxiety and Depression.

Authors:  Qinghua Zou; Yi Jiang; Fangxiang Mu; Ying Shi; Yongfei Fang
Journal:  Med Sci Monit       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.